Georgia Cancer Specialists (GCS) physician Dr. Janice Galleshaw was recently interviewed by Randy and Spiff of the Randy and Spiff Morning Show on 94.9 Lite FM. The radio duo spoke with Dr. Galleshaw concerning Breast Cancer Awareness month, and the importance of early detection of the disease.
“I’m thrilled that I once again had the opportunity to stress the importance of breast cancer prevention and early detection to such a wide audience,” said Dr. Galleshaw.
Over two-thirds of 94.9 Lite FM’s audience is female, allowing Dr. Galleshaw to reach out to large numbers of women in need of her expertise.
Dr. Galleshaw previously gained large amounts of media attention for her work in the STAR (Study of Tamoxifen and Raloxifene) trial, for which she served as principle investigator of the Atlanta region. The breast cancer prevention trial was the largest randomized study of its kind, having enrolled 19,747 women at 400 sites in the U.S., Canada, and Puerto Rico.
This fall she will also participate in a new breast cancer trial that compares the effectiveness of raloxifene to the aromatase inhibitor letrozole. For more information about GCS’s involvement in clinical trials, visit www.gacancer.com/research/.
Dr. Galleshaw offers comprehensive cancer care at the GCS Alpharetta office and the GCS Northside office in Atlanta.